A survey of the burden of XXXX in Europe.

@entity1 @entity7370 @entity2023 @entity66 @entity565
BACKGROUND: The perceptions of @entity1 and physicians regarding the symptoms and impact of @entity2023 ( @entity2023 ) were assessed in a prospective, cross-sectional, international survey. This paper presents the combined survey results from five European countries (Germany, France, Italy, Spain and the UK). METHODS: Data were recorded by 1,482 @entity1 and matched with records from 415 primary care physicians and specialists. Diagnostic tests to confirm @entity2023 had been performed on 1,279 (86.3%) @entity1 . Both physicians and @entity1 recorded the presence, severity and impact of symptoms at the time of consultation in addition to those symptoms frequently, but not currently, present. Health-related quality of life (HRQoL) was assessed using the Mini @entity7370 Quality of Life Questionnaire. RESULTS: A large proportion of @entity1 had moderate-severe disease (67.2%; n = 996), persistent disease (42.5%; n = 630) and comorbidities such as @entity565 (31.5%; n = 467). Overall, @entity1 rated their disease as more severe than did physicians (P < 0.001). At the time of the consultation, one-third of all @entity1 reported that their current nasal and ocular symptoms were moderate or severe in nature. According to the physicians' assessment, good control of nasal and ocular symptoms was achieved in 45.4% (n = 673) and 51.3% (n = 760) of @entity1 , respectively, and poor symptom control in 18.0% (n = 267) and 12.1% (n = 179). Overall, 43.3% (n = 641) of those surveyed were using two or more medicines for their @entity2023 . Health-related quality of life was correlated with disease severity and with the number of days without symptoms in the previous 4 weeks. @entity2023 had a significantly greater impact in @entity1 with more persistent disease than in those with @entity66 (2.3 +/- 1.3 vs 1.9 +/- 1.2; P < 0.001). Nonetheless, 81.8% (n = 601) of @entity1 with @entity66 reported some impairment of their daily life as a result of their @entity2023 . CONCLUSIONS: @entity2023 remains a significant health problem because of the high burden of symptoms and its impact on general well being and HRQoL among @entity1 consulting for this condition. Overall, there was a poor correlation between @entity1 and physicians in the reporting of disease severity.
